Delivery Order SPE2DR25D6028-SPE2DR26FATHY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,414.38 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication. The contract was competitively awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,537.05 delivery order to AmerisourceBergen Drug Corp for levothyroxine sodium on December 29, 2025, with an ultimate completion date of January 27, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Levothyroxine sodium is a synthetic thyroid hormone commonly used to treat hypothyroidism and is a critical pharmaceutical supply for...
- The Defense Logistics Agency awarded a delivery order for levothyroxine sodium to AmerisourceBergen Drug Corp on December 22, 2025, with a ceiling value of $2,962.37 and an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone used to treat hypothyroidism and other thyroid conditions. This firm fixed price delivery order has a ceiling value of $1,801.64 and is scheduled for completion by October 20, 2025. The contract was awarded without a set-aside designation through competitive procurement, with performance taking place at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Levothyroxine 200 micrograms, valued at $1,047.02 under a firm fixed-price contract type. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025. This is an unset-aside competitive award, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Levothyroxine is a synthetic thyroid hormone commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Levothyroxine 200 mcg tablets in quantities of 1,000 units, with a ceiling value of $13,837.62. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for ultimate completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Levothyroxine 150 MCG capsules (30-count units) with a ceiling value of $1,909.37. This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, is unclassified and carries no set-aside designation, indicating it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Levothyroxine 100 mcg/ml vials under a firm fixed-price contract valued at $2,015.19, with completion expected by October 20, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $97,000 to Amerisourcebergen Drug Corporation for the supply of 1,000 boxes of 88 mcg Levothyroxine sodium tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency requirements. No set aside designation or subcontractors were identified. The delivery order was issued under an existing DLA pharmaceutical...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATHYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,887.81 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a thyroid hormone replacement medication. This firm fixed-price delivery order was issued on January 5, 2026, with an ultimate completion date of February 2, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/4/26 |